{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T06:58:23Z","timestamp":1781074703317,"version":"3.54.1"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Malignant rhabdoid tumor of the kidney (MRTK) is a rare and highly aggressive pediatric renal malignancy characterized by early dissemination, frequent presentation in infancy, and persistently poor survival despite multimodal therapy. Over the past decades, intensified treatment strategies combining surgery, multiagent chemotherapy, and selective radiotherapy have modestly improved outcomes, particularly in patients with localized disease. However, infants and those with stage III\/IV or metastatic tumors continue to experience dismal prognosis, highlighting the limitations of further empiric escalation. The molecular hallmark of MRTK is loss of SMARCB1, a core subunit of the SWI\/SNF chromatin-remodeling complex. This event provides a biologic framework for diagnosis, risk interpretation, and therapeutic development, and has shifted attention toward epigenetic and cell-cycle vulnerabilities. Early translational efforts, including EZH2 inhibition and CDK4\/6 blockade, support proof of principle for biomarker-informed treatment, although renal-specific clinical evidence remains limited and single-agent activity has been modest. Immunotherapy and other emerging strategies are also being explored, but their roles in MRTK remain undefined because predictive biomarkers and disease-specific clinical datasets are lacking. In this Mini Review, we summarize the current treatment landscape of MRTK, examine why conventional multimodal therapy remains necessary but insufficient, discuss the preclinical model landscape that supports therapeutic translation, and define major priorities required to move the field toward renal-specific precision care. We argue that the next meaningful advance will depend on collaborative trials that integrate molecular profiling, faithful experimental models, rational combinations, and correlative biomarker studies from diagnosis onward.<\/jats:p>","DOI":"10.3389\/fped.2026.1861712","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T06:16:22Z","timestamp":1781072182000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Current treatment landscape and translational priorities in malignant rhabdoid tumor of the kidney"],"prefix":"10.3389","volume":"14","author":[{"given":"Zhigang","family":"Yao","sequence":"first","affiliation":[{"name":"Department of Urology, Kunming Children\u2019s Hospital (Children\u2019s Hospital Affiliated to Kunming Medical University)","place":["Kunming, China"]},{"name":"Urology Department, The First Affiliated Hospital of Kunming Medical University","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenghao","family":"Zhanghuang","sequence":"additional","affiliation":[{"name":"Department of Urology, Kunming Children\u2019s Hospital (Children\u2019s Hospital Affiliated to Kunming Medical University)","place":["Kunming, China"]},{"name":"Yunnan Province Clinical Research Center for Children\u2019s Health and Disease, Yunnan Key Laboratory of Children\u2019s Major Disease Research","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nian","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Kunming Children\u2019s Hospital (Children\u2019s Hospital Affiliated to Kunming Medical University)","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinrong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Urology, Kunming Children\u2019s Hospital (Children\u2019s Hospital Affiliated to Kunming Medical University)","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zipeng","family":"Hao","sequence":"additional","affiliation":[{"name":"Department of Urology, Kunming Children\u2019s Hospital (Children\u2019s Hospital Affiliated to Kunming Medical University)","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Urology, Kunming Children\u2019s Hospital (Children\u2019s Hospital Affiliated to Kunming Medical University)","place":["Kunming, China"]},{"name":"Yunnan Province Clinical Research Center for Children\u2019s Health and Disease, Yunnan Key Laboratory of Children\u2019s Major Disease Research","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhao","sequence":"additional","affiliation":[{"name":"Urology Department, The First Affiliated Hospital of Kunming Medical University","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e30586","DOI":"10.1002\/pbc.30586","article-title":"Children\u2019s oncology group\u2019s 2023 blueprint for research: renal tumors","volume":"70","author":"Geller","year":"2023","journal-title":"Pediatr Blood Cancer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"279","DOI":"10.4143\/crt.2022.073","article-title":"Epidemiologic and clinical outcomes of pediatric renal tumors in Korea: a retrospective analysis of the Korean pediatric hematology and oncology group data","volume":"55","author":"Koh","year":"2023","journal-title":"Cancer Res Treat"},{"key":"B3","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1186\/s12887-022-03643-1","article-title":"Clinical and prognostic analysis of 42 children with malignant rhabdoid tumor of the kidney: a 7-year retrospective multi-center study","volume":"22","author":"Zhanghuang","year":"2022","journal-title":"BMC Pediatr"},{"key":"B4","doi-asserted-by":"publisher","first-page":"7641","DOI":"10.1200\/JCO.2004.00.8110","article-title":"Rhabdoid tumor of the kidney in the National Wilms\u2019 Tumor Study: age at diagnosis as a prognostic factor","volume":"23","author":"Tomlinson","year":"2005","journal-title":"J Clin Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/pbc.22922","article-title":"Malignant rhabdoid tumours of the kidney (MRTKs), registered on recent SIOP protocols from 1993 to 2005: a report of the SIOP renal tumour study group","volume":"56","author":"van den Heuvel-Eibrink","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e31490","DOI":"10.1002\/pbc.31490","article-title":"Rhabdoid tumor of the kidney and soft tissues: results from National Wilms Tumor Study-5 and Children's Oncology Group study AREN0321","volume":"72","author":"Geller","year":"2025","journal-title":"Pediatr Blood Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00431-023-05345-x","article-title":"Extracranial malignant rhabdoid tumors in children: high mortality even with the help of an aggressive clinical approach","volume":"183","author":"Xie","year":"2024","journal-title":"Eur J Pediatr"},{"key":"B8","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/MPH.0000000000001779","article-title":"Autologous stem cell transplantation for children with renal tumors, and adults with Wilms tumor: retrospective analysis of the Japanese transplant registry unified management program","volume":"42","author":"Kobayashi","year":"2020","journal-title":"J Pediatr Hematol Oncol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"911","DOI":"10.7150\/ijms.51186","article-title":"Factors affecting the outcomes of patients with malignant rhabdoid tumors: a population-based study","volume":"18","author":"Cai","year":"2021","journal-title":"Int J Med Sci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e70219","DOI":"10.1002\/1545-5017.70219","article-title":"Impact of radiation therapy on malignant rhabdoid tumor of the kidney: a national cancer database analysis","volume":"73","author":"Gannon","year":"2026","journal-title":"Pediatr Blood Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1699028","DOI":"10.3389\/fonc.2025.1699028","article-title":"Synchronous malignant rhabdoid tumor of the kidney and adrenal neuroblastoma in an infant treated with proton beam therapy: a case report and literature review","volume":"15","author":"Han","year":"2026","journal-title":"Front Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.3390\/cancers14153645","article-title":"SMARCB1-deficient Cancers: novel molecular insights and therapeutic vulnerabilities","volume":"14","author":"Cooper","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e329","DOI":"10.1016\/S1470-2045(13)70088-3","article-title":"Extracranial rhabdoid tumours: what we have learned so far and future directions","volume":"14","author":"Brennan","year":"2013","journal-title":"Lancet Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1615\/CritRevOncog.2015013566","article-title":"Biology and treatment of rhabdoid tumor","volume":"20","author":"Geller","year":"2015","journal-title":"Crit Rev Oncog"},{"key":"B15","doi-asserted-by":"publisher","first-page":"99380","DOI":"10.5527\/wjn.v14.i2.99380","article-title":"Paediatric renal tumors: an insight into molecular characteristics, histomorphology and syndromic association","volume":"14","author":"Agrawal","year":"2025","journal-title":"World J Nephrol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1093\/jnci\/djad085","article-title":"Tazemetostat for tumors harboring SMARCB1\/SMARCA4 or EZH2 alterations: results from NCI-COG Pediatric MATCH APEC1621C","volume":"115","author":"Chi","year":"2023","journal-title":"J Natl Cancer Inst"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1158\/1078-0432.CCR-16-2898","article-title":"A phase I study of the CDK4\/6 inhibitor ribociclib (LEE011) in pediatric patients with malignant rhabdoid tumors, neuroblastoma, and other solid tumors","volume":"23","author":"Geoerger","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"650","DOI":"10.3390\/biomedicines10030650","article-title":"Immunotherapy for SMARCB1-deficient sarcomas: current evidence and future developments","volume":"10","author":"Ngo","year":"2022","journal-title":"Biomedicines"},{"key":"B19","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.medj.2022.09.002","article-title":"Validation of a non-oncogene encoded vulnerability to exportin 1 inhibition in pediatric renal tumors","volume":"3","author":"Coutinho","year":"2022","journal-title":"Med (N Y)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"843234","DOI":"10.3389\/fmolb.2022.843234","article-title":"Identification of prognostic biomarkers in patients with malignant rhabdoid tumor of the kidney based on mTORC1 signaling pathway-related genes","volume":"9","author":"Zhanghuang","year":"2022","journal-title":"Front Mol Biosci"},{"key":"B21","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s10565-025-10049-z","article-title":"Loss of YTHDF1 suppresses the progression of malignant rhabdoid tumor of the kidney by regulating glutathione S-transferase Mu 2 (GSTM2)","volume":"41","author":"Xiong","year":"2025","journal-title":"Cell Biol Toxicol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11912-025-01644-8","article-title":"Paediatric renal tumors: a state-of-the-art review","volume":"27","author":"Salzillo","year":"2025","journal-title":"Curr Oncol Rep"},{"key":"B23","doi-asserted-by":"publisher","first-page":"659709","DOI":"10.3389\/fonc.2021.659709","article-title":"Clinical and molecular differentiation between malignant rhabdoid tumor of the kidney and normal tissue: a two-case report","volume":"11","author":"Zhanghuang","year":"2021","journal-title":"Front Oncol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1053\/j.semdp.2021.03.007","article-title":"SWI\/SNF-deficient neoplasms of the genitourinary tract","volume":"38","author":"Sirohi","year":"2021","journal-title":"Semin Diagn Pathol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1038\/s41416-026-03348-7","article-title":"Paediatric therapeutic development workshop on rhabdoid tumours","volume":"134","author":"Montiel Equihua","year":"2026","journal-title":"Br J Cancer"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e2300117","DOI":"10.1200\/PO.23.00117","article-title":"Precision medicine for childhood cancer: current limitations and future perspectives","volume":"8","author":"McCabe","year":"2024","journal-title":"JCO Precis Oncol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s11523-025-01178-w","article-title":"From sequencing to survival: the growing role of precision medicine in paediatric oncology","volume":"20","author":"Trinder","year":"2025","journal-title":"Target Oncol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"5837","DOI":"10.1038\/s41467-024-49944-0","article-title":"Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer","volume":"15","author":"Forrest","year":"2024","journal-title":"Nat Commun"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1038\/s41591-024-03044-0","article-title":"Precision-guided treatment in high-risk pediatric cancers","volume":"30","author":"Lau","year":"2024","journal-title":"Nat Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"102161","DOI":"10.1016\/j.labinv.2024.102161","article-title":"Real-world performance of integrative clinical genomics in pediatric precision oncology","volume":"104","author":"Pokorna","year":"2024","journal-title":"Lab Invest"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.32604\/or.2025.065547","article-title":"Implementation of a pediatric oncology precision medicine clinic to personalize approaches for diagnosing and treating solid tumors","volume":"33","author":"Keane","year":"2025","journal-title":"Oncol Res"},{"key":"B32","doi-asserted-by":"publisher","first-page":"101878","DOI":"10.1016\/j.xcrm.2024.101878","article-title":"Metabolic profiling of patient-derived organoids reveals nucleotide synthesis as a metabolic vulnerability in malignant rhabdoid tumors","volume":"6","author":"Kes","year":"2025","journal-title":"Cell Rep Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s43018-022-00474-y","article-title":"The clinical utility of integrative genomics in childhood cancer extends beyond targetable mutations","volume":"4","author":"Villani","year":"2023","journal-title":"Nat Cancer"},{"key":"B34","doi-asserted-by":"publisher","first-page":"7762","DOI":"10.1038\/s41467-023-43498-3","article-title":"SMARCB1 Loss activates patient-specific distal oncogenic enhancers in malignant rhabdoid tumors","volume":"14","author":"Liu","year":"2023","journal-title":"Nat Commun"},{"key":"B35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41392-024-01760-0","article-title":"New clinical trial design in precision medicine: discovery, development and direction","volume":"9","author":"Duan","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B36","first-page":"375","article-title":"The G401 cell line, utilized for studies of chromosomal changes in Wilms\u2019 tumor, is derived from a rhabdoid tumor of the kidney","volume":"142","author":"Garvin","year":"1993","journal-title":"Am J Pathol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.stemcr.2018.07.010","article-title":"In vivo expansion of cancer stemness affords novel cancer stem cell targets: malignant rhabdoid tumor as an example","volume":"11","author":"Golan","year":"2018","journal-title":"Stem Cell Rep"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/s41467-020-15155-6","article-title":"An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity","volume":"11","author":"Calandrini","year":"2020","journal-title":"Nat Commun"},{"key":"B39","doi-asserted-by":"publisher","first-page":"109568","DOI":"10.1016\/j.celrep.2021.109568","article-title":"Organoid-based drug screening reveals neddylation as therapeutic target for malignant rhabdoid tumors","volume":"36","author":"Calandrini","year":"2021","journal-title":"Cell Rep"},{"key":"B40","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/s41388-019-1027-8","article-title":"High-risk blastemal Wilms tumor can be modeled by 3D spheroid cultures in vitro","volume":"39","author":"Wegert","year":"2020","journal-title":"Oncogene"},{"key":"B41","doi-asserted-by":"publisher","first-page":"908","DOI":"10.3390\/cancers18060908","article-title":"Tumor microenvironment and immune response against Wilms tumor: evasion mechanisms and implications for immunotherapeutic approaches","volume":"18","author":"Cantoni","year":"2026","journal-title":"Cancers (Basel)"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1861712\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T06:16:23Z","timestamp":1781072183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1861712\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":41,"alternative-id":["10.3389\/fped.2026.1861712"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1861712","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"article-number":"1861712"}}